SCHEMBL6865601

SCHEMBL6865601

FC(F)(F)c1cc(Cl)cc(Cl)c1.O=S(=O)(Cl)Cl

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.48
NOTUM Q6P988 1/20 0.41
TSHR P16473 2/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP3A4 P08684 1/20 0.41
HPGD P15428 1/20 0.41
ALOX15 P16050 1/20 0.41
HIF1A Q16665 1/20 0.41
TXNRD1 Q16881 1/20 0.41
TXNRD3 Q86VQ6 1/20 0.41
TXNRD2 Q9NNW7 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RAPGEF4 Q8WZA2 1/20 0.41
ACLY P53396 3/20 0.40
SLC13A3 Q8WWT9 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL321756 0.87 AHR (0.52) AHRNOTUMTSHRALDH1A1CYP3A4
SCHEMBL2055460 0.83 ACLY (0.44) AHRNOTUMRAPGEF4ACLYLMNA
Nitrogen SCHEMBL9592328 0.82 AHR (0.48) AHRNOTUMTSHRALDH1A1CYP3A4
SCHEMBL3786224 0.82 RAPGEF4 (0.47) AHRNOTUMTSHRALDH1A1CYP3A4
Nitrogen SCHEMBL28987389 0.80 AHR (0.47) AHRNOTUMTSHRALDH1A1CYP3A4
1,3,5-Trichlorobenzene SCHEMBL4216819 0.79 TSHR (0.61) AHRTSHRALDH1A1CYP3A4ACLY
SCHEMBL2033058 0.79 MEN1 (0.50) TSHRALDH1A1CYP3A4LMNAMAPT
SCHEMBL271423 0.78 GAA (0.36) AHRNOTUMCYP3A4TDP1RAPGEF4
SCHEMBL17204219 0.76 NOTUM (0.41) AHRNOTUMTSHRALDH1A1CYP3A4
SCHEMBL27596196 0.76 AHR (0.48) AHRALDH1A1CYP3A4LMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6818772-B2 DIETETICS, SLEEP DISORDERS, EATING DISORDERS, SEXUAL DISORDERS, CENTRAL NERVOUS SYSTEM DISORDERS, PSYCHOLOGICAL DISORDERS ABBOTT LABORATORIES 2004-11-16 US disclosed
US-20030229119-A1 Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor ABBVIE INC. 2003-12-11 US disclosed
WO-2003070244-A1 ANTAGONIST OF MELANIN CONCENTRATING HORMONE AND THEIR USES ABBOTT LABORATORIES (US) 2003-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030229119-A1 Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor MCHR1, MCHR2, MC1R AHR 565/4885NOTUM 4185/4885TSHR 13/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.